Actemra shortage spills over to include Sanofi’s rival KevzaraRoche’s Actemra has been in high demand since its value in treating severe COVID-19 was established, leading to Share XActemra shortage spills over to include Sanofi’s rival Kevzarahttps://pharmaphorum.com/news/actemra-shortage-spills-over-to-include-sanofis-rival-kevzara/
Amid Actemra shortage, WHO asks Roche to ensure equitable accessRoche’s arthritis drug Actemra has become a key treatment for people with severe COVID-19, leading to shortages, and Share XAmid Actemra shortage, WHO asks Roche to ensure equitable accesshttps://pharmaphorum.com/news/amid-actemra-shortage-who-asks-roche-to-ensure-equitable-access/
Sanofi to combat shortages with European medicines ingredient firmSanofi is to create a European company focused on production and marketing of active pharmaceutical ingredients (API) – Share XSanofi to combat shortages with European medicines ingredient firmhttps://pharmaphorum.com/news/sanofi-to-combat-shortages-with-european-medicines-ingredient-firm/
